Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 4
1991 2
1992 5
1993 2
1994 3
1995 2
1996 1
1997 1
1998 6
1999 2
2000 8
2001 6
2002 3
2003 5
2004 6
2005 2
2006 3
2007 3
2008 7
2009 9
2010 3
2012 4
2013 3
2014 2
2015 2
2016 2
2019 1
2020 1
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
NPY L7P polymorphism and metabolic diseases.
Pesonen U. Pesonen U. Regul Pept. 2008 Aug 7;149(1-3):51-5. doi: 10.1016/j.regpep.2007.08.028. Epub 2008 Apr 3. Regul Pept. 2008. PMID: 18499283 Review.
Neurophysiology and genetics of burning mouth syndrome.
Kolkka M, Forssell H, Virtanen A, Puhakka A, Pesonen U, Jääskeläinen SK. Kolkka M, et al. Among authors: pesonen u. Eur J Pain. 2019 Jul;23(6):1153-1161. doi: 10.1002/ejp.1382. Epub 2019 Mar 12. Eur J Pain. 2019. PMID: 30793423 Free article.
Novel delivery systems for improving the clinical use of peptides.
Kovalainen M, Mönkäre J, Riikonen J, Pesonen U, Vlasova M, Salonen J, Lehto VP, Järvinen K, Herzig KH. Kovalainen M, et al. Among authors: pesonen u. Pharmacol Rev. 2015 Jul;67(3):541-61. doi: 10.1124/pr.113.008367. Pharmacol Rev. 2015. PMID: 26023145 Review.
5-HT6 receptor antagonists. Design, synthesis, and structure-activity relationship of substituted 2-(1-methyl-4-piperazinyl)pyridines.
Gałęzowski M, Fabritius CH, Pesonen U, Salo H, Olszak-Płachta M, Czerwińska K, Adamczyk J, Król M, Prusis P, Sieprawska-Lupa M, Mikulski M, Kuokkanen K, Obuchowicz R, Korjamo T, Jalava N, Nikiforuk A, Nowak M. Gałęzowski M, et al. Among authors: pesonen u. Bioorg Med Chem Lett. 2023 Nov 15;96:129497. doi: 10.1016/j.bmcl.2023.129497. Epub 2023 Oct 6. Bioorg Med Chem Lett. 2023. PMID: 37806499
1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.
Fabritius CH, Pesonen U, Messinger J, Horvath R, Salo H, Gałęzowski M, Galek M, Stefańska K, Szeremeta-Spisak J, Olszak-Płachta M, Buda A, Adamczyk J, Król M, Prusis P, Sieprawska-Lupa M, Mikulski M, Kuokkanen K, Chapman H, Obuchowicz R, Korjamo T, Jalava N, Nowak M. Fabritius CH, et al. Among authors: pesonen u. Bioorg Med Chem Lett. 2016 Jun 1;26(11):2610-5. doi: 10.1016/j.bmcl.2016.04.024. Epub 2016 Apr 23. Bioorg Med Chem Lett. 2016. PMID: 27117428
[Neuropeptide Y and serum cholesterol].
Uusitupa MI, Karvonen MK, Pesonen U, Koulu M. Uusitupa MI, et al. Among authors: pesonen u. Duodecim. 1999;115(3):241-2. Duodecim. 1999. PMID: 11830869 Finnish. No abstract available.
97 results